Pancreatic Cancer Treatment Market By Treatment Type (Surgery {Whipple Procedure, Distal Pancreatectomy, Total Pancreatectomy}, Radiation Therapy, Chemotherapy, Targeted Therapy, Immunotherapy, Palliative Care, Others), By Drug Type (Approved Drugs {Gemcitabine, Nab-Paclitaxel, Erlotinib, Liposomal Irinotecan}, Pipeline Drugs {Oncolytic Viruses, Epigenetic Modulators}), By Cancer Type (Exocrine Pancreatic Cancer, Pancreatic Neuroendocrine Tumors, Others), By Route of Administration (Oral, Injectable {Intravenous, Intraperitoneal}), and By End-User (Hospitals, Ambulatory Surgical Centers, Cancer Research Institutes, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035
Published Date: Dec 2024 | Report ID: MI1582 | 210 Pages
Report Coverage:
By Treatment Type
- Surgery
- Whipple Procedure
- Distal Pancreatectomy
- Total Pancreatectomy
- Radiation Therapy
- Chemotherapy
- Targeted Therapy
- Immunotherapy
- Palliative Care
- Others
By Drug Type
Approved Drugs
- Gemcitabine
- Nab-Paclitaxel
- Erlotinib
- Liposomal Irinotecan
- Pipeline Drugs
- Oncolytic Viruses
- Epigenetic Modulators
By Cancer Type
- Exocrine Pancreatic Cancer
- Pancreatic Neuroendocrine Tumors
- Others
By Route of Administration
- Oral
- Injectable
- Intravenous
- Intraperitoneal
By End-User
- Hospitals
- Ambulatory Surgical Centers (ASCs)
- Cancer Research Institutes
- Others
By Region
North America
- U.S.
- Canada
Europe
- U.K.
- France
- Germany
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Singapore
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of Middle East & Africa
List of Companies:
- Celgene Corporation
- Eli Lilly and Co.
- Amgen Inc.
- Merck & Co.
- Genentech
- Novartis International AG
- AbbVie Inc.
- Bayer AG
- Sanofi
- Ipsen Pharma
- Bristol-Myers Squibb
- OncoOne
- Exelixis, Inc.
- Karyopharm Therapeutics
- Clovis Oncology
Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!
Our analysts are ready to help you immediately.